Uricosuric properties of diflunisal in man. 1979

A Dresse, and P Fischer, and M A Gerard, and K F Tempero, and M A Meisinger, and J A Bolognese, and L Verhaest

1 The uricosuric effect of diflunisal was studied in eleven normal subjects. 2 Urine and serum uric acid levels were measured and used to assess the effect. 3 Diflunisal caused statistically significant decreases in serum uric acid levels and increases in uric acid clearance at 250 and 375 mg twice daily. 4 Diflunisal taken on an empty stomach caused epigastric discomfort in the high dose group which was obviated when the drug was taken with meals. 5 Diflunisal caused no abnormalities in the measured haematological, urological or biochemical parameters.

UI MeSH Term Description Entries
D008297 Male Males
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D012459 Salicylates The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis. Salicylate,Salicylic Acids,Acids, Salicylic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014527 Uric Acid An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN. 2,6,8-Trihydroxypurine,Ammonium Acid Urate,Monosodium Urate,Monosodium Urate Monohydrate,Potassium Urate,Sodium Acid Urate,Sodium Acid Urate Monohydrate,Sodium Urate,Sodium Urate Monohydrate,Trioxopurine,Urate,Acid Urate, Ammonium,Acid Urate, Sodium,Acid, Uric,Monohydrate, Monosodium Urate,Monohydrate, Sodium Urate,Urate Monohydrate, Monosodium,Urate Monohydrate, Sodium,Urate, Ammonium Acid,Urate, Monosodium,Urate, Potassium,Urate, Sodium,Urate, Sodium Acid
D014528 Uricosuric Agents Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma. Uricosuric Agent,Agent, Uricosuric,Agents, Uricosuric

Related Publications

A Dresse, and P Fischer, and M A Gerard, and K F Tempero, and M A Meisinger, and J A Bolognese, and L Verhaest
January 1978, Nephron,
A Dresse, and P Fischer, and M A Gerard, and K F Tempero, and M A Meisinger, and J A Bolognese, and L Verhaest
January 1980, Advances in experimental medicine and biology,
A Dresse, and P Fischer, and M A Gerard, and K F Tempero, and M A Meisinger, and J A Bolognese, and L Verhaest
January 1977, Advances in experimental medicine and biology,
A Dresse, and P Fischer, and M A Gerard, and K F Tempero, and M A Meisinger, and J A Bolognese, and L Verhaest
September 1958, The American journal of medicine,
A Dresse, and P Fischer, and M A Gerard, and K F Tempero, and M A Meisinger, and J A Bolognese, and L Verhaest
January 1977, Advances in experimental medicine and biology,
A Dresse, and P Fischer, and M A Gerard, and K F Tempero, and M A Meisinger, and J A Bolognese, and L Verhaest
February 1972, The Journal of pharmacology and experimental therapeutics,
A Dresse, and P Fischer, and M A Gerard, and K F Tempero, and M A Meisinger, and J A Bolognese, and L Verhaest
March 1983, Pharmacotherapy,
A Dresse, and P Fischer, and M A Gerard, and K F Tempero, and M A Meisinger, and J A Bolognese, and L Verhaest
January 1983, Pharmacotherapy,
A Dresse, and P Fischer, and M A Gerard, and K F Tempero, and M A Meisinger, and J A Bolognese, and L Verhaest
May 1996, Biochemistry and molecular biology international,
A Dresse, and P Fischer, and M A Gerard, and K F Tempero, and M A Meisinger, and J A Bolognese, and L Verhaest
May 1958, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!